Table 3 Coefficients of the brain, liver, spleen, heart and kidney
From: Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral route in repeated dose study
Groups | Body weight (g) | Brain (mg/g) | Liver (mg/g) | Heart (mg/g) | Spleen (mg/g) | Kidney (mg/g) |
|---|---|---|---|---|---|---|
ZALH (n = 8) | 300 ± 25 | 5.61 ± 0.93 | 35.67 ± 1.53 | 4.00 ± 0.53 | 1.99 ± 0.37 | 4.19 ± 0.20 |
ZALL (n = 8) | 342 ± 30 | 5.76 ± 0.55 | 36.27 ± 3.35 | 3.90 ± 0.53 | 2.08 ± 0.20 | 4.16 ± 0.22 |
ZAH (n = 8) | 337 ± 25 | 5.62 ± 0.31 | 30.14 ± 3.54 | 3.91 ± 0 .43 | 2.32 ± 0.26 | 3.98 ± 0. 23 |
ZAL (n = 8) | 335 ± 47 | 5.22 ± 0.68 | 31.83 ± 4.12 | 4.50 ± 0.44 | 2.29 ± 0.19 | 3.93 ± 0.45 |
VC (n = 8) | 332 ± 14 | 5.31 ± 0.70 | 28.25 ± 2.71 | 3.86 ± 0 .35 | 1.88 ± 0.19 | 3.59 ± 0.39 |